Lei Miao

机构：China Pharmaceutical University, Peking University, National Institutes of Pharmaceutical Research and Development (China), Peking University International Hospital, State Key Laboratory of Natural and Biomimetic Drugs

发表论文 3 篇 · 总被引 1 次 · h-index 1

代表论文

• FAP-Synergistic Organ-Targeted mRNA-LNP for Overcoming Delivery Barriers in Hepatic and Pulmonary Fibrosis (2026 · Journal of the American Chemical Society · 被引 1)
• FXR-mediated recruitment of PPP1CB suppresses SMAD2/3 phosphorylation to mitigate pulmonary fibrosis (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Synergistic integration of inducible RNA switches enhances the manipulation of vector expression (2026 · bioRxiv (Cold Spring Harbor Laboratory))